Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 5,000 shares at $141.99 ($710K) on 2017-01-12, disclosed to the SEC on 2017-01-12.
Seasonal sale ($710k) by Director — this insider has traded UTHR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |